| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microfilament motor activity | 4.16e-08 | 38 | 104 | 6 | GO:0000146 | |
| GeneOntologyMolecularFunction | aryl sulfotransferase activity | 1.42e-07 | 10 | 104 | 4 | GO:0004062 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.88e-07 | 118 | 104 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | 3'-phosphoadenosine 5'-phosphosulfate binding | 4.79e-07 | 13 | 104 | 4 | GO:0050656 | |
| GeneOntologyMolecularFunction | tyrosine-ester sulfotransferase activity | 5.47e-07 | 4 | 104 | 3 | GO:0017067 | |
| GeneOntologyMolecularFunction | amine sulfotransferase activity | 5.47e-07 | 4 | 104 | 3 | GO:0047685 | |
| GeneOntologyMolecularFunction | flavonol 3-sulfotransferase activity | 1.36e-06 | 5 | 104 | 3 | GO:0047894 | |
| GeneOntologyMolecularFunction | actin filament binding | 2.92e-06 | 227 | 104 | 9 | GO:0051015 | |
| GeneOntologyMolecularFunction | steroid sulfotransferase activity | 4.73e-06 | 7 | 104 | 3 | GO:0050294 | |
| GeneOntologyMolecularFunction | sulfate binding | 1.13e-05 | 9 | 104 | 3 | GO:0043199 | |
| GeneOntologyMolecularFunction | PLC activating G protein-coupled glutamate receptor activity | 2.69e-05 | 2 | 104 | 2 | GO:0001639 | |
| GeneOntologyMolecularFunction | calmodulin binding | 2.73e-05 | 230 | 104 | 8 | GO:0005516 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration | 1.60e-04 | 4 | 104 | 2 | GO:0099583 | |
| GeneOntologyMolecularFunction | sulfotransferase activity | 1.93e-04 | 55 | 104 | 4 | GO:0008146 | |
| GeneOntologyMolecularFunction | actin binding | 2.00e-04 | 479 | 104 | 10 | GO:0003779 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential | 2.66e-04 | 5 | 104 | 2 | GO:0099530 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 3.27e-04 | 26 | 104 | 3 | GO:0005248 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYO1G MYH10 MYO1A MYO1C MYO1D IPP ARFGEF1 MYO1B AIF1L NEB FABP3 MAGI2 EEF2 NISCH NIN | 5.59e-04 | 1099 | 104 | 15 | GO:0008092 |
| GeneOntologyMolecularFunction | transferase activity, transferring sulphur-containing groups | 6.04e-04 | 74 | 104 | 4 | GO:0016782 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor activity | 9.44e-04 | 9 | 104 | 2 | GO:0098988 | |
| GeneOntologyMolecularFunction | adenylate cyclase inhibiting G protein-coupled glutamate receptor activity | 9.44e-04 | 9 | 104 | 2 | GO:0001640 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYO1G DNAH3 MYH10 ATP7B MYO1A MYO1C MYO1D MYO1B SRPRA DNAH12 | 1.37e-03 | 614 | 104 | 10 | GO:0140657 |
| GeneOntologyMolecularFunction | aminopeptidase activity | 1.46e-03 | 43 | 104 | 3 | GO:0004177 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 2.02e-03 | 171 | 104 | 5 | GO:0015081 | |
| GeneOntologyMolecularFunction | sodium ion binding | 2.35e-03 | 14 | 104 | 2 | GO:0031402 | |
| GeneOntologyMolecularFunction | sodium channel activity | 2.52e-03 | 52 | 104 | 3 | GO:0005272 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 8.09e-08 | 153 | 104 | 9 | GO:0030048 | |
| GeneOntologyBiologicalProcess | actin filament-based process | DOCK2 MYO1G MYH10 MYO1A MYO1C MYO1D DVL2 ARFGEF1 ARHGAP17 MYO1B AIF1L NEB RUFY3 FAT1 NISCH SCN3A SCN7A SCN9A BAIAP2 | 1.31e-07 | 912 | 104 | 19 | GO:0030029 |
| GeneOntologyBiologicalProcess | 4-nitrophenol metabolic process | 1.24e-06 | 5 | 104 | 3 | GO:0018960 | |
| GeneOntologyBiologicalProcess | 3'-phosphoadenosine 5'-phosphosulfate metabolic process | 1.38e-06 | 17 | 104 | 4 | GO:0050427 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside bisphosphate metabolic process | 1.38e-06 | 17 | 104 | 4 | GO:0034035 | |
| GeneOntologyBiologicalProcess | actin filament organization | MYO1G MYH10 MYO1A MYO1C MYO1D ARFGEF1 ARHGAP17 MYO1B AIF1L NEB RUFY3 FAT1 BAIAP2 | 1.71e-06 | 509 | 104 | 13 | GO:0007015 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | DOCK2 MYO1G MYH10 MYO1A MYO1C MYO1D DVL2 ARFGEF1 ARHGAP17 MYO1B AIF1L NEB RUFY3 FAT1 NISCH BAIAP2 | 2.59e-06 | 803 | 104 | 16 | GO:0030036 |
| GeneOntologyBiologicalProcess | sulfation | 9.79e-06 | 27 | 104 | 4 | GO:0051923 | |
| GeneOntologyBiologicalProcess | response to corticosteroid | 4.26e-05 | 185 | 104 | 7 | GO:0031960 | |
| GeneOntologyBiologicalProcess | organophosphate metabolic process | PLBD1 PDK3 ACLY GPX4 ALDH1L1 PGK1 STAT3 FABP3 PARP1 SULT1A2 SULT1A4 PNPLA6 SULT1A3 SULT1C3 GNAI3 OGA SLC44A3 | 5.46e-05 | 1142 | 104 | 17 | GO:0019637 |
| GeneOntologyBiologicalProcess | purine nucleotide metabolic process | PDK3 ACLY ALDH1L1 PGK1 STAT3 PARP1 SULT1A2 SULT1A4 SULT1A3 SULT1C3 GNAI3 OGA | 6.70e-05 | 619 | 104 | 12 | GO:0006163 |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled glutamate receptor signaling pathway | 7.53e-05 | 3 | 104 | 2 | GO:0007206 | |
| GeneOntologyBiologicalProcess | ethanol catabolic process | 8.04e-05 | 17 | 104 | 3 | GO:0006068 | |
| GeneOntologyBiologicalProcess | nucleoside bisphosphate metabolic process | 8.35e-05 | 142 | 104 | 6 | GO:0033865 | |
| GeneOntologyBiologicalProcess | ribonucleoside bisphosphate metabolic process | 8.35e-05 | 142 | 104 | 6 | GO:0033875 | |
| GeneOntologyBiologicalProcess | purine nucleoside bisphosphate metabolic process | 8.35e-05 | 142 | 104 | 6 | GO:0034032 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | MYO1G MYH10 EPPK1 MYO1A MYO1C MYO1D ARFGEF1 ARHGAP17 MYO1B AIF1L NEB RUFY3 FAT1 BAIAP2 NIN | 8.91e-05 | 957 | 104 | 15 | GO:0097435 |
| GeneOntologyBiologicalProcess | ethanol metabolic process | 9.62e-05 | 18 | 104 | 3 | GO:0006067 | |
| GeneOntologyBiologicalProcess | purine-containing compound metabolic process | PDK3 ACLY ALDH1L1 PGK1 STAT3 PARP1 SULT1A2 SULT1A4 SULT1A3 SULT1C3 GNAI3 OGA | 1.09e-04 | 652 | 104 | 12 | GO:0072521 |
| GeneOntologyBiologicalProcess | response to glucocorticoid | 1.61e-04 | 160 | 104 | 6 | GO:0051384 | |
| GeneOntologyBiologicalProcess | nucleotide metabolic process | PDK3 ACLY ALDH1L1 PGK1 STAT3 PARP1 SULT1A2 SULT1A4 SULT1A3 SULT1C3 GNAI3 OGA | 1.71e-04 | 684 | 104 | 12 | GO:0009117 |
| GeneOntologyBiologicalProcess | nucleoside phosphate metabolic process | PDK3 ACLY ALDH1L1 PGK1 STAT3 PARP1 SULT1A2 SULT1A4 SULT1A3 SULT1C3 GNAI3 OGA | 1.88e-04 | 691 | 104 | 12 | GO:0006753 |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 2.05e-04 | 23 | 104 | 3 | GO:0034310 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide metabolic process | PDK3 ACLY PGK1 STAT3 PARP1 SULT1A2 SULT1A4 SULT1A3 SULT1C3 GNAI3 | 2.64e-04 | 512 | 104 | 10 | GO:0009150 |
| GeneOntologyBiologicalProcess | response to interleukin-17 | 3.34e-04 | 27 | 104 | 3 | GO:0097396 | |
| GeneOntologyBiologicalProcess | ribonucleotide metabolic process | PDK3 ACLY PGK1 STAT3 PARP1 SULT1A2 SULT1A4 SULT1A3 SULT1C3 GNAI3 | 3.62e-04 | 533 | 104 | 10 | GO:0009259 |
| GeneOntologyBiologicalProcess | ribose phosphate metabolic process | PDK3 ACLY PGK1 STAT3 PARP1 SULT1A2 SULT1A4 SULT1A3 SULT1C3 GNAI3 | 4.02e-04 | 540 | 104 | 10 | GO:0019693 |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule metabolic process | PDK3 ACLY ALDH1L1 PGK1 STAT3 PARP1 SULT1A2 SULT1A4 SULT1A3 SULT1C3 GNAI3 OGA | 4.83e-04 | 767 | 104 | 12 | GO:0055086 |
| GeneOntologyBiologicalProcess | regulation of membrane potential | 5.26e-04 | 559 | 104 | 10 | GO:0042391 | |
| GeneOntologyBiologicalProcess | behavioral response to pain | 5.55e-04 | 32 | 104 | 3 | GO:0048266 | |
| GeneOntologyCellularComponent | myosin complex | 4.77e-07 | 59 | 104 | 6 | GO:0016459 | |
| GeneOntologyCellularComponent | actin-based cell projection | 1.04e-05 | 278 | 104 | 9 | GO:0098858 | |
| GeneOntologyCellularComponent | filopodium | 3.48e-05 | 123 | 104 | 6 | GO:0030175 | |
| GeneOntologyCellularComponent | cell leading edge | MYO1G MYH10 MYO1A MYO1C MYO1D AIF1L RUFY3 DUOX1 FAT1 CNTNAP2 BAIAP2 | 3.95e-05 | 500 | 104 | 11 | GO:0031252 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 7.73e-05 | 17 | 104 | 3 | GO:0001518 | |
| GeneOntologyCellularComponent | somatodendritic compartment | MYH10 MYO1A MYO1D GRM1 TMEM222 GRM5 TENM2 RUFY3 FABP7 MAGI2 CNNM4 SERPINI1 SCN3A CNTNAP2 ELAVL4 BAIAP2 NIN | 1.13e-04 | 1228 | 104 | 17 | GO:0036477 |
| GeneOntologyCellularComponent | cell-cell junction | EPPK1 ATP7B ANXA6 ARHGAP17 PTPRU TENM2 FABP7 MAGI2 FAT1 CNTNAP2 BAIAP2 | 1.74e-04 | 591 | 104 | 11 | GO:0005911 |
| GeneOntologyCellularComponent | growth cone | 2.26e-04 | 245 | 104 | 7 | GO:0030426 | |
| GeneOntologyCellularComponent | site of polarized growth | 2.74e-04 | 253 | 104 | 7 | GO:0030427 | |
| GeneOntologyCellularComponent | dendrite | MYH10 MYO1D GRM1 TMEM222 GRM5 TENM2 RUFY3 MAGI2 CNNM4 CNTNAP2 ELAVL4 BAIAP2 NIN | 3.33e-04 | 858 | 104 | 13 | GO:0030425 |
| GeneOntologyCellularComponent | anchoring junction | EPPK1 ATP7B ANXA6 ARHGAP17 AIF1L PTPRU THSD1 TENM2 RUFY3 FABP7 MAGI2 FAT1 CNTNAP2 BAIAP2 | 3.38e-04 | 976 | 104 | 14 | GO:0070161 |
| GeneOntologyCellularComponent | dendritic tree | MYH10 MYO1D GRM1 TMEM222 GRM5 TENM2 RUFY3 MAGI2 CNNM4 CNTNAP2 ELAVL4 BAIAP2 NIN | 3.40e-04 | 860 | 104 | 13 | GO:0097447 |
| GeneOntologyCellularComponent | microvillus | 3.76e-04 | 123 | 104 | 5 | GO:0005902 | |
| GeneOntologyCellularComponent | sodium channel complex | 3.98e-04 | 29 | 104 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | actin cytoskeleton | 5.98e-04 | 576 | 104 | 10 | GO:0015629 | |
| GeneOntologyCellularComponent | neuronal cell body | MYH10 MYO1A MYO1D GRM1 RUFY3 FABP7 CNNM4 SERPINI1 SCN3A CNTNAP2 ELAVL4 BAIAP2 | 9.06e-04 | 835 | 104 | 12 | GO:0043025 |
| GeneOntologyCellularComponent | brush border | 9.82e-04 | 152 | 104 | 5 | GO:0005903 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.07e-03 | 10 | 104 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | mitotic spindle pole | 1.28e-03 | 43 | 104 | 3 | GO:0097431 | |
| GeneOntologyCellularComponent | neuron spine | 1.48e-03 | 247 | 104 | 6 | GO:0044309 | |
| GeneOntologyCellularComponent | axon | MYH10 MYO1A MYO1D GRM1 NDRG2 TENM2 RUFY3 SCN3A CNTNAP2 SCN9A ELAVL4 NIN | 1.58e-03 | 891 | 104 | 12 | GO:0030424 |
| GeneOntologyCellularComponent | basal plasma membrane | 1.96e-03 | 354 | 104 | 7 | GO:0009925 | |
| GeneOntologyCellularComponent | cell body | MYH10 MYO1A MYO1D GRM1 RUFY3 FABP7 CNNM4 SERPINI1 SCN3A CNTNAP2 ELAVL4 BAIAP2 | 2.23e-03 | 929 | 104 | 12 | GO:0044297 |
| GeneOntologyCellularComponent | sarcoplasm | 2.54e-03 | 114 | 104 | 4 | GO:0016528 | |
| GeneOntologyCellularComponent | apical part of cell | 2.79e-03 | 592 | 104 | 9 | GO:0045177 | |
| GeneOntologyCellularComponent | basal part of cell | 2.83e-03 | 378 | 104 | 7 | GO:0045178 | |
| GeneOntologyCellularComponent | leading edge membrane | 4.01e-03 | 210 | 104 | 5 | GO:0031256 | |
| GeneOntologyCellularComponent | bicellular tight junction | 4.18e-03 | 131 | 104 | 4 | GO:0005923 | |
| GeneOntologyCellularComponent | axolemma | 4.84e-03 | 21 | 104 | 2 | GO:0030673 | |
| GeneOntologyCellularComponent | tight junction | 5.15e-03 | 139 | 104 | 4 | GO:0070160 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 5.17e-03 | 223 | 104 | 5 | GO:0098862 | |
| GeneOntologyCellularComponent | perikaryon | 5.17e-03 | 223 | 104 | 5 | GO:0043204 | |
| GeneOntologyCellularComponent | extrinsic component of postsynaptic membrane | 5.31e-03 | 22 | 104 | 2 | GO:0098890 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 5.32e-03 | 320 | 104 | 6 | GO:0016323 | |
| Domain | Myosin_TH1 | 1.01e-10 | 7 | 104 | 5 | PF06017 | |
| Domain | Myosin_TH1 | 1.01e-10 | 7 | 104 | 5 | IPR010926 | |
| Domain | TH1 | 1.01e-10 | 7 | 104 | 5 | PS51757 | |
| Domain | IQ | 1.62e-08 | 81 | 104 | 8 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 3.74e-08 | 90 | 104 | 8 | IPR000048 | |
| Domain | Myosin_head_motor_dom | 6.16e-08 | 38 | 104 | 6 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 6.16e-08 | 38 | 104 | 6 | PS51456 | |
| Domain | Myosin_head | 6.16e-08 | 38 | 104 | 6 | PF00063 | |
| Domain | MYSc | 6.16e-08 | 38 | 104 | 6 | SM00242 | |
| Domain | IQ | 1.34e-07 | 71 | 104 | 7 | PF00612 | |
| Domain | IQ | 8.66e-07 | 93 | 104 | 7 | PS50096 | |
| Domain | Na_channel_asu | 1.96e-05 | 10 | 104 | 3 | IPR001696 | |
| Domain | Na_trans_assoc | 1.96e-05 | 10 | 104 | 3 | IPR010526 | |
| Domain | Na_trans_assoc | 1.96e-05 | 10 | 104 | 3 | PF06512 | |
| Domain | GluR_Homer-bdg | 3.07e-05 | 2 | 104 | 2 | PF10606 | |
| Domain | Metabotropic_Glu_rcpt_Homer-bd | 3.07e-05 | 2 | 104 | 2 | IPR019588 | |
| Domain | Endosulphine | 3.07e-05 | 2 | 104 | 2 | IPR006760 | |
| Domain | GPCR_3_mtglu_rcpt_1 | 3.07e-05 | 2 | 104 | 2 | IPR001256 | |
| Domain | GluR_Homer-bdg | 3.07e-05 | 2 | 104 | 2 | SM01229 | |
| Domain | GPCR_3_mtglu_rcpt_5 | 3.07e-05 | 2 | 104 | 2 | IPR000202 | |
| Domain | Endosulfine | 3.07e-05 | 2 | 104 | 2 | PF04667 | |
| Domain | Sulfotransfer_1 | 4.66e-05 | 36 | 104 | 4 | PF00685 | |
| Domain | Sulfotransferase_dom | 4.66e-05 | 36 | 104 | 4 | IPR000863 | |
| Domain | iLBP | 8.91e-05 | 16 | 104 | 3 | IPR031259 | |
| Domain | Fatty_acid-bd | 8.91e-05 | 16 | 104 | 3 | IPR000463 | |
| Domain | FABP | 8.91e-05 | 16 | 104 | 3 | PS00214 | |
| Domain | EF-hand-dom_pair | 2.03e-04 | 287 | 104 | 8 | IPR011992 | |
| Domain | P-loop_NTPase | MYO1G DNAH3 MYH10 MYO1A MYO1C MYO1D MYO1B SRPRA MAGI2 SULT1A2 EEF2 DNAH12 SULT1C3 GNAI3 | 2.53e-04 | 848 | 104 | 14 | IPR027417 |
| Domain | Na_trans_cytopl | 4.54e-04 | 6 | 104 | 2 | PF11933 | |
| Domain | Na_trans_cytopl | 4.54e-04 | 6 | 104 | 2 | IPR024583 | |
| Domain | ERAP1-like_C_dom | 8.41e-04 | 8 | 104 | 2 | IPR024571 | |
| Domain | GPCR_3_mtglu_rcpt | 8.41e-04 | 8 | 104 | 2 | IPR000162 | |
| Domain | Calx_beta | 8.41e-04 | 8 | 104 | 2 | SM00237 | |
| Domain | ERAP1_C | 8.41e-04 | 8 | 104 | 2 | PF11838 | |
| Domain | cNMP | 8.85e-04 | 34 | 104 | 3 | SM00100 | |
| Domain | Lipocln_cytosolic_FA-bd_dom | 8.85e-04 | 34 | 104 | 3 | IPR000566 | |
| Domain | Lipocalin | 8.85e-04 | 34 | 104 | 3 | PF00061 | |
| Domain | cNMP-bd_dom | 9.64e-04 | 35 | 104 | 3 | IPR000595 | |
| Domain | - | 9.64e-04 | 35 | 104 | 3 | 2.40.128.20 | |
| Domain | CNMP_BINDING_3 | 9.64e-04 | 35 | 104 | 3 | PS50042 | |
| Domain | Calx_beta | 1.08e-03 | 9 | 104 | 2 | IPR003644 | |
| Domain | Calx-beta | 1.08e-03 | 9 | 104 | 2 | PF03160 | |
| Domain | Calycin-like | 1.14e-03 | 37 | 104 | 3 | IPR011038 | |
| Domain | Calycin | 1.14e-03 | 37 | 104 | 3 | IPR012674 | |
| Domain | cNMP-bd-like | 1.23e-03 | 38 | 104 | 3 | IPR018490 | |
| Domain | Peptidase_M1 | 1.95e-03 | 12 | 104 | 2 | IPR001930 | |
| Domain | Peptidase_M1_N | 2.30e-03 | 13 | 104 | 2 | IPR014782 | |
| Domain | NCD3G | 2.30e-03 | 13 | 104 | 2 | PF07562 | |
| Domain | Peptidase_M1 | 2.30e-03 | 13 | 104 | 2 | PF01433 | |
| Domain | GPCR_3_9-Cys_dom | 2.30e-03 | 13 | 104 | 2 | IPR011500 | |
| Domain | - | 2.42e-03 | 48 | 104 | 3 | 2.60.120.10 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.68e-03 | 14 | 104 | 2 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 2.68e-03 | 14 | 104 | 2 | IPR013602 | |
| Domain | DHC_N2 | 2.68e-03 | 14 | 104 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 2.68e-03 | 14 | 104 | 2 | IPR011704 | |
| Domain | AAA_8 | 2.68e-03 | 14 | 104 | 2 | PF12780 | |
| Domain | GPCR_3_CS | 2.68e-03 | 14 | 104 | 2 | IPR017979 | |
| Domain | AAA_5 | 2.68e-03 | 14 | 104 | 2 | PF07728 | |
| Domain | RmlC-like_jellyroll | 2.88e-03 | 51 | 104 | 3 | IPR014710 | |
| Domain | DHC_fam | 3.08e-03 | 15 | 104 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 3.08e-03 | 15 | 104 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 3.08e-03 | 15 | 104 | 2 | IPR004273 | |
| Domain | Ion_trans_dom | 3.79e-03 | 114 | 104 | 4 | IPR005821 | |
| Domain | Ion_trans | 3.79e-03 | 114 | 104 | 4 | PF00520 | |
| Domain | Channel_four-helix_dom | 3.95e-03 | 57 | 104 | 3 | IPR027359 | |
| Domain | - | 3.95e-03 | 57 | 104 | 3 | 1.20.120.350 | |
| Domain | Poly(ADP-ribose)pol_cat_dom | 3.95e-03 | 17 | 104 | 2 | IPR012317 | |
| Domain | PARP_CATALYTIC | 3.95e-03 | 17 | 104 | 2 | PS51059 | |
| Domain | PARP | 3.95e-03 | 17 | 104 | 2 | PF00644 | |
| Domain | - | 3.95e-03 | 17 | 104 | 2 | 3.90.228.10 | |
| Domain | RUN | 4.43e-03 | 18 | 104 | 2 | SM00593 | |
| Domain | RUN | 4.94e-03 | 19 | 104 | 2 | PS50826 | |
| Domain | RUN | 4.94e-03 | 19 | 104 | 2 | PF02759 | |
| Domain | Run_dom | 4.94e-03 | 19 | 104 | 2 | IPR004012 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_PHIP_TO_DNA_ADDUCTS | 1.95e-06 | 5 | 83 | 3 | M47807 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 3.54e-05 | 32 | 83 | 4 | M27455 | |
| Pathway | KEGG_SULFUR_METABOLISM | 5.39e-05 | 13 | 83 | 3 | M18256 | |
| Pathway | WP_SULFATION_BIOTRANSFORMATION_REACTION | 1.26e-04 | 17 | 83 | 3 | M39483 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MYH10 EPPK1 MYO1C MYO1D ACLY CAMK2G MYO1B SRPRA RPS24 THOC3 PGK1 PARP1 EEF2 PNPLA6 RBM15B POLR1B GNAI3 BAIAP2 IK VDAC3 | 1.06e-09 | 1257 | 105 | 20 | 36526897 |
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | MYH10 MYO1A MYO1C MYO1D NPEPPS MYO1B RPS24 PGK1 PARP1 EEF2 GNAI3 | 1.30e-09 | 288 | 105 | 11 | 31501420 |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | MXRA5 MYO1C MYO1D ACLY NPEPPS ANXA6 GPX4 MYO1B AIF1L ALDH1L1 NEB FABP3 EEF2 FAT1 GNAI3 BAIAP2 VDAC3 | 1.06e-08 | 1016 | 105 | 17 | 19056867 |
| Pubmed | 1.62e-08 | 10 | 105 | 4 | 7601475 | ||
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | MYH10 EPPK1 MYO1C MYO1D ACLY MYO1B SRPRA RPS24 PGK1 PARP1 EEF2 GNAI3 BAIAP2 | 2.32e-08 | 580 | 105 | 13 | 35676659 |
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 18599791 | ||
| Pubmed | Mammalian myosin I alpha, I beta, and I gamma: new widely expressed genes of the myosin I family. | 2.67e-08 | 3 | 105 | 3 | 8449986 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | MYO1C ACLY NPEPPS CAMK2G MYO1B SRPRA PSMD8 RPS24 THOC3 PARP1 SPCS3 EEF2 TIAL1 POLR1B GNAI3 IK OGA VDAC3 | 4.01e-08 | 1257 | 105 | 18 | 37317656 |
| Pubmed | Identification of FBXO25-interacting proteins using an integrated proteomics approach. | 5.21e-08 | 112 | 105 | 7 | 20473970 | |
| Pubmed | MYH10 MYO1C MYO1D ACLY NPEPPS CAMK2G RPS24 ALDH1L1 GRM1 GRM5 PGK1 RUFY3 MAGI2 PARP1 EEF2 PNPLA6 NISCH BAIAP2 VDAC3 | 5.28e-08 | 1431 | 105 | 19 | 37142655 | |
| Pubmed | Structural and chemical profiling of the human cytosolic sulfotransferases. | 5.49e-08 | 13 | 105 | 4 | 17425406 | |
| Pubmed | MYH10 MYO1A MYO1C MYO1D CAMK2G SIK1 KRBA2 MYO1B PSMD8 NEB PGK1 PARP1 SPCS3 EEF2 TIAL1 SCN9A IFT122 GNAI3 VDAC3 | 5.95e-08 | 1442 | 105 | 19 | 35575683 | |
| Pubmed | DOCK2 MYO1G ATP7B MYO1C ACLY CAMK2G ANXA6 RPS24 PGK1 PARP1 EEF2 PNPLA6 NISCH PDZD8 IFT122 GNAI3 OGA | 7.94e-08 | 1168 | 105 | 17 | 19946888 | |
| Pubmed | 1.07e-07 | 4 | 105 | 3 | 24318996 | ||
| Pubmed | 1.07e-07 | 4 | 105 | 3 | 33414449 | ||
| Pubmed | 1.07e-07 | 4 | 105 | 3 | 8943792 | ||
| Pubmed | A single mutation converts the nucleotide specificity of phenol sulfotransferase from PAP to AMP. | 1.07e-07 | 4 | 105 | 3 | 12390022 | |
| Pubmed | Differential localization and dynamics of class I myosins in the enterocyte microvillus. | 1.07e-07 | 4 | 105 | 3 | 20089841 | |
| Pubmed | 1.07e-07 | 4 | 105 | 3 | 8424956 | ||
| Pubmed | 1.07e-07 | 4 | 105 | 3 | 8288252 | ||
| Pubmed | 1.07e-07 | 4 | 105 | 3 | 25370010 | ||
| Pubmed | MYH10 ACLY NPEPPS ANXA6 MYO1B SRPRA THOC3 PGK1 STAT3 PARP1 SPCS3 EEF2 ARHGEF40 TIAL1 RBM15B GNAI3 BAIAP2 VDAC3 | 1.47e-07 | 1371 | 105 | 18 | 36244648 | |
| Pubmed | Repression of rRNA transcription by PARIS contributes to Parkinson's disease. | 1.50e-07 | 272 | 105 | 9 | 25315684 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | DOCK2 MYH10 EPPK1 MYO1C ACLY NPEPPS MYO1B RPS24 ALDH1L1 PGK1 PARP1 DUOX1 EEF2 VDAC3 | 1.53e-07 | 807 | 105 | 14 | 30575818 |
| Pubmed | MYH10 NPEPPS CAMK2G DVL2 GRM1 GRM5 TENM2 PGK1 MAGI2 PARP1 EEF2 NISCH ELAVL4 TNKS BAIAP2 | 2.12e-07 | 963 | 105 | 15 | 28671696 | |
| Pubmed | 2.53e-07 | 45 | 105 | 5 | 22114352 | ||
| Pubmed | 2.66e-07 | 5 | 105 | 3 | 8812438 | ||
| Pubmed | 2.66e-07 | 5 | 105 | 3 | 11389699 | ||
| Pubmed | 2.66e-07 | 5 | 105 | 3 | 29908303 | ||
| Pubmed | 2.66e-07 | 5 | 105 | 3 | 25053625 | ||
| Pubmed | 2.66e-07 | 5 | 105 | 3 | 24802129 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | KDM5B MYH10 MYO1A MYO1C NPEPPS CAMK2G GPX4 USP25 THOC3 PARP1 SHCBP1 POLR1B TNKS OGA NIN | 3.64e-07 | 1005 | 105 | 15 | 19615732 |
| Pubmed | MYH10 EPPK1 MYO1C MYO1D MYO1B SRPRA RPS24 AIF1L PGK1 PARP1 VDAC3 | 3.81e-07 | 503 | 105 | 11 | 36217030 | |
| Pubmed | Myosin-I isozymes in neonatal rodent auditory and vestibular epithelia. | 5.31e-07 | 6 | 105 | 3 | 12486594 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYO1G MYH10 EPPK1 MYO1A MYO1C MYO1D ACLY NPEPPS MYO1B PSMD8 PGK1 EEF2 | 6.27e-07 | 647 | 105 | 12 | 26618866 |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | MYH10 MYO1C MYO1D ACLY NPEPPS ANXA6 ALDH1L1 PGK1 FABP3 FREM2 EEF2 SERPINI1 TIMP1 BAIAP2 PMP2 | 7.98e-07 | 1070 | 105 | 15 | 23533145 |
| Pubmed | 9.28e-07 | 7 | 105 | 3 | 12438748 | ||
| Pubmed | 9.28e-07 | 7 | 105 | 3 | 10722873 | ||
| Pubmed | 9.28e-07 | 7 | 105 | 3 | 9370299 | ||
| Pubmed | PDK3 NPEPPS GPX4 ARHGAP17 SRPRA ALDH1L1 STAT3 CNNM4 SPCS3 PNPLA6 TIAL1 NISCH | 1.16e-06 | 686 | 105 | 12 | 28380382 | |
| Pubmed | USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. | MYH10 MYO1C MYO1D NPEPPS MYO1B RPS24 PARP1 EEF2 NISCH POLR1B VDAC3 | 1.19e-06 | 565 | 105 | 11 | 33567341 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MYH10 MYO1C MYO1D ACLY NPEPPS ANXA6 MYO1B PSMD8 RPS24 GRM1 THOC3 PGK1 PARP1 EEF2 RBM15B IK VDAC3 | 1.27e-06 | 1425 | 105 | 17 | 30948266 |
| Pubmed | Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain. | 1.48e-06 | 8 | 105 | 3 | 10594240 | |
| Pubmed | 1.48e-06 | 463 | 105 | 10 | 34901782 | ||
| Pubmed | KDM5B USP25 RPS24 TMEM222 PGK1 STAT3 RUFY3 MAGI2 PARP1 EEF2 NAA25 NISCH PDZD8 TNKS IFT122 BAIAP2 | 1.56e-06 | 1285 | 105 | 16 | 35914814 | |
| Pubmed | 1.63e-06 | 65 | 105 | 5 | 32120844 | ||
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 1.64e-06 | 268 | 105 | 8 | 33024031 | |
| Pubmed | MYH10 PDK3 CAMK2G DVL2 SRPRA RPS24 GRM5 TENM2 PGK1 RUFY3 FABP7 MAGI2 CNTNAP2 ELAVL4 BAIAP2 | 1.73e-06 | 1139 | 105 | 15 | 36417873 | |
| Pubmed | 2.22e-06 | 9 | 105 | 3 | 8887328 | ||
| Pubmed | Ethanol sulfation by the human cytosolic sulfotransferases: a systematic analysis. | 2.22e-06 | 9 | 105 | 3 | 23207770 | |
| Pubmed | 2.22e-06 | 9 | 105 | 3 | 19548878 | ||
| Pubmed | 2.22e-06 | 9 | 105 | 3 | 9177785 | ||
| Pubmed | 2.22e-06 | 9 | 105 | 3 | 9166597 | ||
| Pubmed | 2.22e-06 | 9 | 105 | 3 | 8468045 | ||
| Pubmed | Chromosomal localization of the mouse genes encoding the ERK1 and ERK2 isoforms of MAP kinases. | 2.22e-06 | 9 | 105 | 3 | 9060415 | |
| Pubmed | 2.57e-06 | 383 | 105 | 9 | 29331416 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 2.84e-06 | 498 | 105 | 10 | 36634849 | |
| Pubmed | 2.87e-06 | 289 | 105 | 8 | 37132043 | ||
| Pubmed | A trimeric Rab7 GEF controls NPC1-dependent lysosomal cholesterol export. | 3.10e-06 | 392 | 105 | 9 | 33144569 | |
| Pubmed | 3.27e-06 | 506 | 105 | 10 | 30890647 | ||
| Pubmed | MYH10 MYO1C MYO1D MYO1B SRPRA PSMD8 PTPRU CNNM4 PARP1 PDZD8 BAIAP2 IK ENSA NIN | 3.39e-06 | 1049 | 105 | 14 | 27880917 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | MYH10 EPPK1 MYO1C NPEPPS ANXA6 DVL2 ARFGEF1 PSMD8 RPS24 PGK1 PARP1 EEF2 NAA25 GNAI3 BAIAP2 ENSA | 3.45e-06 | 1367 | 105 | 16 | 32687490 |
| Pubmed | DOCK2 EPPK1 ACLY CAMK2G ANXA6 ARHGAP17 SRPRA PGK1 ARHGEF40 NISCH SHCBP1 TNKS VDAC3 | 4.04e-06 | 916 | 105 | 13 | 32203420 | |
| Pubmed | Localization of the murine cholecystokinin A and B receptor genes. | 4.33e-06 | 11 | 105 | 3 | 7613026 | |
| Pubmed | 4.33e-06 | 11 | 105 | 3 | 11154739 | ||
| Pubmed | Tbx6, a mouse T-Box gene implicated in paraxial mesoderm formation at gastrulation. | 4.33e-06 | 11 | 105 | 3 | 8954725 | |
| Pubmed | Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes. | 4.33e-06 | 11 | 105 | 3 | 9034160 | |
| Pubmed | 4.33e-06 | 11 | 105 | 3 | 10720750 | ||
| Pubmed | MYH10 EPPK1 MYO1C MYO1D ACLY NPEPPS ANXA6 MYO1B RPS24 PGK1 IK | 4.75e-06 | 653 | 105 | 11 | 22586326 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | ACLY DVL2 ARFGEF1 SRPRA PSMD8 CNNM4 SPCS3 NAA25 ARHGEF40 PNPLA6 NISCH OGA VDAC3 | 5.46e-06 | 942 | 105 | 13 | 31073040 |
| Pubmed | Identification of four chromosomal loci determining obesity in a multifactorial mouse model. | 5.77e-06 | 12 | 105 | 3 | 7706460 | |
| Pubmed | DNAH3 MYH10 MYO1C ACLY ANXA6 MYO1B RPS24 PGK1 STAT3 PARP1 EEF2 TIMP1 | 5.80e-06 | 803 | 105 | 12 | 36517590 | |
| Pubmed | 6.55e-06 | 430 | 105 | 9 | 32581705 | ||
| Pubmed | 7.09e-06 | 327 | 105 | 8 | 31409639 | ||
| Pubmed | Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. | 7.09e-06 | 327 | 105 | 8 | 15592455 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MYH10 EPPK1 MYO1C MYO1D ACLY NPEPPS MYO1B PSMD8 MAGI2 CNNM4 NAA25 SHCBP1 BAIAP2 ENSA VDAC3 | 7.36e-06 | 1284 | 105 | 15 | 17353931 |
| Pubmed | 7.48e-06 | 13 | 105 | 3 | 10585447 | ||
| Pubmed | Fatty Acid Binding Protein 3 Is Involved in n-3 and n-6 PUFA transport in mouse trophoblasts. | 7.48e-06 | 13 | 105 | 3 | 25122651 | |
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | ARPP19 ACLY ANXA6 ALDH1L1 NDRG2 RUFY3 PARP1 EEF2 SCN7A ELAVL4 | 7.69e-06 | 558 | 105 | 10 | 35063084 |
| Pubmed | An Interaction Network of the Human SEPT9 Established by Quantitative Mass Spectrometry. | 8.84e-06 | 43 | 105 | 4 | 30975701 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 22028929 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 9185557 | ||
| Pubmed | ARPP-16/ARPP-19: a highly conserved family of cAMP-regulated phosphoproteins. | 9.03e-06 | 2 | 105 | 2 | 11279279 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 21900877 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 16877361 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 22681774 | ||
| Pubmed | Na+ current properties in islet α- and β-cells reflect cell-specific Scn3a and Scn9a expression. | 9.03e-06 | 2 | 105 | 2 | 25172946 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 29705271 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 23280324 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 8719884 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 21143341 | ||
| Pubmed | Metabotropic glutamate receptors in the main olfactory bulb drive granule cell-mediated inhibition. | 9.03e-06 | 2 | 105 | 2 | 17093122 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 32812201 | ||
| Pubmed | Molecular study of 33 families with Fraser syndrome new data and mutation review. | 9.03e-06 | 2 | 105 | 2 | 18671281 | |
| Pubmed | DOCK2 interacts with FLT3 and modulates the survival of FLT3-expressing leukemia cells. | 9.03e-06 | 2 | 105 | 2 | 27748370 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 32643034 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 35450028 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 20471941 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 31102766 | ||
| Pubmed | Localization of fatty acid binding proteins (FABPs) in the cochlea of mice. | 9.03e-06 | 2 | 105 | 2 | 20685095 | |
| Interaction | SULT1A3 interactions | 1.24e-07 | 24 | 103 | 5 | int:SULT1A3 | |
| Interaction | USP11 interactions | MYO1G MYH10 MYO1C MYO1D NPEPPS MYO1B ALDH1L1 PGK1 PARP1 EEF2 RBM15B POLR1B GNAI3 VDAC3 | 6.28e-07 | 539 | 103 | 14 | int:USP11 |
| Interaction | MAPT interactions | ARPP19 ACLY NPEPPS CAMK2G ANXA6 DVL2 SIK1 SRPRA PSMD8 ALDH1L1 NDRG2 PGK1 RUFY3 PARP1 EEF2 ARHGEF40 SCN7A ELAVL4 BAIAP2 VDAC3 | 8.25e-07 | 1119 | 103 | 20 | int:MAPT |
| Interaction | CLEC4D interactions | 9.16e-07 | 261 | 103 | 10 | int:CLEC4D | |
| Interaction | HDAC6 interactions | MYH10 EPPK1 MYO1C MYO1D ACLY MYO1B SRPRA RPS24 PGK1 STAT3 RUFY3 PARP1 EEF2 FAT1 PDZD8 POLR1B GNAI3 BAIAP2 | 1.01e-06 | 929 | 103 | 18 | int:HDAC6 |
| Interaction | TMPRSS2 interactions | MYH10 EPPK1 MYO1C MYO1D MYO1B SRPRA AIF1L TMEM222 PDZD8 GNAI3 VDAC3 | 1.23e-06 | 337 | 103 | 11 | int:TMPRSS2 |
| Interaction | DPP4 interactions | MYH10 MYO1C MYO1D MYO1B SRPRA AIF1L CNNM4 NISCH PDZD8 GNAI3 BAIAP2 VDAC3 | 3.46e-06 | 453 | 103 | 12 | int:DPP4 |
| Interaction | KCTD13 interactions | MYH10 MYO1C MYO1D ACLY NPEPPS CAMK2G USP25 RPS24 ALDH1L1 GRM1 GRM5 PGK1 RUFY3 FABP7 MAGI2 PARP1 EEF2 PNPLA6 NISCH BAIAP2 VDAC3 | 6.35e-06 | 1394 | 103 | 21 | int:KCTD13 |
| Interaction | TAGLN interactions | 6.77e-06 | 90 | 103 | 6 | int:TAGLN | |
| Interaction | MYO1A interactions | 7.49e-06 | 25 | 103 | 4 | int:MYO1A | |
| Interaction | ZIC3 interactions | 7.49e-06 | 25 | 103 | 4 | int:ZIC3 | |
| Interaction | CLEC4E interactions | 1.33e-05 | 353 | 103 | 10 | int:CLEC4E | |
| Interaction | TFCP2 interactions | MYH10 MYO1A MYO1C MYO1D NPEPPS MYO1B RPS24 PGK1 PARP1 EEF2 GNAI3 | 1.43e-05 | 436 | 103 | 11 | int:TFCP2 |
| Interaction | PIM3 interactions | 1.76e-05 | 63 | 103 | 5 | int:PIM3 | |
| Interaction | SULT2A1 interactions | 2.08e-05 | 11 | 103 | 3 | int:SULT2A1 | |
| Interaction | NXPH2 interactions | 2.35e-05 | 33 | 103 | 4 | int:NXPH2 | |
| Interaction | SULT1A1 interactions | 2.38e-05 | 67 | 103 | 5 | int:SULT1A1 | |
| Interaction | ZNF746 interactions | 4.49e-05 | 326 | 103 | 9 | int:ZNF746 | |
| Interaction | ISG15 interactions | MYH10 EPPK1 MYO1C ACLY MYO1B PSMD8 PGK1 PARP1 EEF2 RBM15B OGA | 4.50e-05 | 494 | 103 | 11 | int:ISG15 |
| Interaction | CTNNB1 interactions | FLT3 MYH10 MYO1C ACLY DVL2 ARFGEF1 MYO1B RPS24 PTPRU NDRG2 PGK1 MAGI2 PARP1 EEF2 CNTNAP2 TNKS | 5.14e-05 | 1009 | 103 | 16 | int:CTNNB1 |
| Interaction | XAGE1A interactions | 5.63e-05 | 41 | 103 | 4 | int:XAGE1A | |
| Interaction | IFITM3 interactions | EPPK1 MYO1C MYO1D DVL2 MYO1B AIF1L FAM241A RUFY3 GNAI3 BAIAP2 VDAC3 | 6.31e-05 | 513 | 103 | 11 | int:IFITM3 |
| Interaction | ST8SIA4 interactions | 7.09e-05 | 84 | 103 | 5 | int:ST8SIA4 | |
| Interaction | FBXO25 interactions | 7.10e-05 | 198 | 103 | 7 | int:FBXO25 | |
| Interaction | SNCA interactions | MYH10 ARPP19 MYO1C ACLY CAMK2G ANXA6 DVL2 MYO1B SRPRA RUFY3 FABP7 PARP1 ENSA | 7.28e-05 | 716 | 103 | 13 | int:SNCA |
| Interaction | KIF20A interactions | MYH10 EPPK1 MYO1A MYO1C MYO1D SIK1 MYO1B RPS24 PARP1 EEF2 PDZD8 POLR1B TNKS GNAI3 IK VDAC3 | 8.41e-05 | 1052 | 103 | 16 | int:KIF20A |
| Interaction | CTTN interactions | MYO1C ACLY CAMK2G ARHGAP17 MYO1B RPS24 AIF1L PARP1 RBM15B NIN | 1.03e-04 | 450 | 103 | 10 | int:CTTN |
| Interaction | C9orf72 interactions | MYO1C ACLY NPEPPS CAMK2G MYO1B SRPRA PSMD8 RPS24 THOC3 PARP1 SPCS3 EEF2 TIAL1 POLR1B GNAI3 IK OGA VDAC3 | 1.16e-04 | 1319 | 103 | 18 | int:C9orf72 |
| Interaction | IQCB1 interactions | 1.18e-04 | 370 | 103 | 9 | int:IQCB1 | |
| Interaction | SULT1C2 interactions | 1.18e-04 | 19 | 103 | 3 | int:SULT1C2 | |
| Interaction | TAGLN2 interactions | 1.37e-04 | 220 | 103 | 7 | int:TAGLN2 | |
| Interaction | AR interactions | KDM5B MYH10 EPPK1 EFCAB6 MYO1C MYO1D ACLY MYO1B PGK1 STAT3 PARP1 EEF2 NISCH GNAI3 IK | 1.53e-04 | 992 | 103 | 15 | int:AR |
| Interaction | CDH5 interactions | 2.43e-04 | 109 | 103 | 5 | int:CDH5 | |
| Interaction | LOXL2 interactions | 2.54e-04 | 410 | 103 | 9 | int:LOXL2 | |
| Interaction | PTEN interactions | MYH10 MYO1C MYO1D CAMK2G DVL2 USP25 MYO1B THOC3 PGK1 MAGI2 PARP1 EEF2 TNKS VDAC3 | 2.68e-04 | 929 | 103 | 14 | int:PTEN |
| Interaction | AGR2 interactions | DOCK2 MYH10 EPPK1 MYO1C ACLY NPEPPS MYO1B RPS24 ALDH1L1 PGK1 PARP1 DUOX1 EEF2 VDAC3 | 2.83e-04 | 934 | 103 | 14 | int:AGR2 |
| Interaction | HINT1 interactions | 2.89e-04 | 176 | 103 | 6 | int:HINT1 | |
| Cytoband | 16p12.1 | 2.58e-05 | 25 | 105 | 3 | 16p12.1 | |
| Cytoband | 2q24 | 2.81e-04 | 11 | 105 | 2 | 2q24 | |
| Cytoband | 10q22 | 7.74e-04 | 18 | 105 | 2 | 10q22 | |
| Cytoband | 3p14.3 | 2.16e-03 | 30 | 105 | 2 | 3p14.3 | |
| GeneFamily | Myosins, class I | 3.88e-11 | 8 | 69 | 5 | 1097 | |
| GeneFamily | Sulfotransferases, cytosolic | 1.89e-07 | 14 | 69 | 4 | 762 | |
| GeneFamily | Fatty acid binding protein family | 2.87e-05 | 16 | 69 | 3 | 550 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 3.96e-04 | 8 | 69 | 2 | 281 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 5.08e-04 | 9 | 69 | 2 | 1203 | |
| GeneFamily | Dyneins, axonemal | 1.88e-03 | 17 | 69 | 2 | 536 | |
| GeneFamily | Aminopeptidases|CD molecules | 1.88e-03 | 17 | 69 | 2 | 104 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 1.88e-03 | 17 | 69 | 2 | 684 | |
| Coexpression | TABULA_MURIS_SENIS_AORTA_FIBROBLAST_OF_CARDIAC_TISSUE_AGEING | MYH10 ARPP19 MYO1D GPX4 ARFGEF1 PSMD8 PTPRU THOC3 NDRG2 SULT1A2 RSAD2 SULT1A4 SULT1A3 VDAC3 | 1.05e-06 | 723 | 104 | 14 | MM3672 |
| Coexpression | GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_DN | 1.28e-06 | 198 | 104 | 8 | M3352 | |
| Coexpression | KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP | CAMK2G ANXA6 GPX4 PSMD8 RPS24 PGK1 FABP7 SERPINI1 PNPLA6 NISCH OGA ENSA VDAC3 | 3.02e-06 | 680 | 104 | 13 | M2107 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | KCNH8 ARFGEF1 GRM1 NEB GRM5 TENM2 RUFY3 MAGI2 SERPINI1 ERAP2 SCN3A CNTNAP2 SCN9A ELAVL4 TNKS ARMH4 | 7.32e-06 | 1106 | 104 | 16 | M39071 |
| Coexpression | LE_EGR2_TARGETS_DN | 7.39e-06 | 117 | 104 | 6 | MM1139 | |
| Coexpression | HU_FETAL_RETINA_RGC | 1.09e-05 | 443 | 104 | 10 | M39269 | |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_UP | KCNH8 ATP7B MYO1A CAMK2G GPX4 MYO1B PTPRU GRM1 GRM5 EEF2 SULT1C3 SCN3A SCN7A SCN9A ELAVL4 DNASE1L3 TAT | 1.14e-05 | 1281 | 104 | 17 | M1884 |
| Coexpression | KIM_ALL_DISORDERS_CALB1_CORR_UP | ARPP19 CAMK2G ANXA6 GPX4 PSMD8 PGK1 EEF2 SERPINI1 OGA ENSA VDAC3 | 1.15e-05 | 547 | 104 | 11 | M2110 |
| Coexpression | TSANG_PBMC_FLUVIRIN_PANDEMRIX_ADULT_CORR_WITH_CELL_FREQ_CD27HI_CD38HI_CD20_NEG_PLASMABLASTS_AND_CD38PLUS_OF_IGD_CD27PLUS_MEM_B_CELLS_7DY_POSITIVE | 1.50e-05 | 78 | 104 | 5 | M41196 | |
| Coexpression | GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_45MIN_DN | 1.54e-05 | 200 | 104 | 7 | M6639 | |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_DN | ARPP19 DIPK1A NPEPPS USP25 SRPRA PGK1 FABP3 FABP7 PARP1 SERPINI1 SCN3A CNTNAP2 ELAVL4 OGA ENSA VDAC3 | 3.23e-05 | 1248 | 104 | 16 | M17728 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | DOCK2 MYO1G ARPP19 ANXA6 USP25 SRPRA DPP8 PGK1 STAT3 PARP1 SPCS3 TIAL1 ERAP2 GNAI3 IK OGA NIN | 7.78e-05 | 1492 | 104 | 17 | M40023 |
| Coexpression | VERNOCHET_ADIPOGENESIS | 1.16e-04 | 24 | 104 | 3 | MM1317 | |
| Coexpression | GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP | 1.45e-04 | 199 | 104 | 6 | M3474 | |
| Coexpression | GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN | 1.45e-04 | 199 | 104 | 6 | M7319 | |
| Coexpression | GSE8835_CD4_VS_CD8_TCELL_CLL_PATIENT_UP | 1.49e-04 | 200 | 104 | 6 | M6256 | |
| Coexpression | GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP | 1.49e-04 | 200 | 104 | 6 | M6625 | |
| Coexpression | GSE17721_CTRL_VS_POLYIC_4H_BMDC_DN | 1.49e-04 | 200 | 104 | 6 | M3714 | |
| Coexpression | GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_UP | 1.49e-04 | 200 | 104 | 6 | M7135 | |
| Coexpression | SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1DY_DN | 1.55e-04 | 5 | 104 | 2 | M41007 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.86e-09 | 177 | 105 | 8 | d05497d2c80a66ec6a4e1733fea3a5534877a6a7 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.23e-08 | 182 | 105 | 8 | ecb5624c9074cc6449fad961df54c926c2681d54 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-08 | 184 | 105 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-08 | 184 | 105 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-08 | 184 | 105 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-08 | 189 | 105 | 8 | 3a295c215b5c18e7c673f92b7af5be523421682c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-08 | 194 | 105 | 8 | be869e186386d03ebb670971dd24fa656b4b0edf | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-08 | 194 | 105 | 8 | 4d6c9b016e3a0641954a8ea10c97d1cd76fadd9f | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.83e-07 | 193 | 105 | 7 | 66af80f4b51e1ce97b6fb7c630dc5f95bfa7e7d4 | |
| ToppCell | normal_Lung-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 1.77e-06 | 154 | 105 | 6 | 835ef49d314ecbcbfd8d1041ba202a5eedcda0bd | |
| ToppCell | 343B-Myeloid-Dendritic-cDC1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.77e-06 | 154 | 105 | 6 | 71d33b5dbfab5820e3daddb01806a69116ba8008 | |
| ToppCell | IIF-Lymphocyte-T_NK-ILC|IIF / Disease, Lineage and Cell Type | 2.14e-06 | 159 | 105 | 6 | 55e4f21548f480ca414c00cbff5ec3b13bafd271 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.65e-06 | 165 | 105 | 6 | fead3f2032f8fa5f7f0159a4434989b3d65debbb | |
| ToppCell | B_cells-pDCs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.94e-06 | 168 | 105 | 6 | dc8f94424f60ab56facdcffa969e7f3466ee1b6e | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-06 | 169 | 105 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Proliferative_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.25e-06 | 171 | 105 | 6 | 59d79c3e36a4930af42ebc96f05570641b9fb864 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.51e-06 | 181 | 105 | 6 | 22363c5835dd6cef8f895ab9362e0837d92b15b1 | |
| ToppCell | CTRL-Myeloid-cDC|Myeloid / Disease state, Lineage and Cell class | 4.66e-06 | 182 | 105 | 6 | ee137574b8f0e684a4a7cb26226877c471cae433 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.81e-06 | 183 | 105 | 6 | b5ede5a0048c585b73c00e88aeddbcaf669347b1 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-06 | 185 | 105 | 6 | 11c147f3f5570c4761d2bcff3bad28146b4a5861 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Dendritic-DC2|GI_small-bowel / Manually curated celltypes from each tissue | 5.12e-06 | 185 | 105 | 6 | f78be85dd6e443abb7af20f98ff351c1131ece4d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.44e-06 | 187 | 105 | 6 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.61e-06 | 188 | 105 | 6 | 1f912ea015f50570e848259d948a0ba682d64bb4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.61e-06 | 188 | 105 | 6 | 505b6b4277d7dea87aee27191d0acca67928b8e6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.78e-06 | 189 | 105 | 6 | 784ace2be87f2ecb19490f4974f63a559516e0eb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-06 | 189 | 105 | 6 | bfc76a72b600d641c8fe58346e5d8986c34f3981 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-06 | 189 | 105 | 6 | fc88c51ace7d883c01617f3f9b5fab70cc91cc09 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.96e-06 | 190 | 105 | 6 | 11d3c31167ea71809b4cc3757a0c6ea54a448602 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 5.96e-06 | 190 | 105 | 6 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-06 | 191 | 105 | 6 | f932980baa032748857cb367a55c37dd975c693e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.33e-06 | 192 | 105 | 6 | 0bb06738e1c3ec0c044a7ee61f6cf1d4781fb53c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.33e-06 | 192 | 105 | 6 | 9e031bf93eb8757fdd0cc22f01b44e48f85532d5 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.33e-06 | 192 | 105 | 6 | 3d777d07878269b87ec7e1f06489cae7c989d633 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.33e-06 | 192 | 105 | 6 | d5ec4cdb15620a5abfc83577353501186c2bc86a | |
| ToppCell | LAM-Myeloid-DC|Myeloid / Condition, Lineage and Cell class | 6.52e-06 | 193 | 105 | 6 | f665cce40053ae5d6e28f9f70ddf78e8598c9514 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-1|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 6.52e-06 | 193 | 105 | 6 | c2673d86f7d7b849788036032a93a6d136a70040 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.52e-06 | 193 | 105 | 6 | e7012f7b53971972299db34fa51ff51a4e4987fe | |
| ToppCell | COVID-19-kidney-CD-PC|kidney / Disease (COVID-19 only), tissue and cell type | 6.52e-06 | 193 | 105 | 6 | 738689d009e4b118d7ce3171a207294b95cbe78b | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 6.52e-06 | 193 | 105 | 6 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.52e-06 | 193 | 105 | 6 | d994b2f2707877288f88cab7cd6002ef91962c50 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.52e-06 | 193 | 105 | 6 | 5da60321bcf761913eb30779b6d8b1e933c5e51e | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.72e-06 | 194 | 105 | 6 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.72e-06 | 194 | 105 | 6 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | PBMC-Mild|PBMC / Compartment, Disease Groups and Clusters | 6.72e-06 | 194 | 105 | 6 | d1366b169d14011194e61d16b6b0953349febc78 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-oRG|World / Primary Cells by Cluster | 6.72e-06 | 194 | 105 | 6 | 3a4bf6a7fac0e5bdbb4bb17041806d06a75974d9 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.72e-06 | 194 | 105 | 6 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | Monocytes-cDCs|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 7.33e-06 | 197 | 105 | 6 | 15cb9fe1c3bab80bd24728fd9ac7ba385912ac33 | |
| ToppCell | BAL-Mild-cDC_10|Mild / Compartment, Disease Groups and Clusters | 7.33e-06 | 197 | 105 | 6 | c0550d41dd5619b369b590f3d6a61154dd7b2cab | |
| ToppCell | Healthy/Control-cDC|Healthy/Control / Disease group and Cell class | 7.33e-06 | 197 | 105 | 6 | 926423aae9fcf654f84b0f7621103a6a22d3aced | |
| ToppCell | Healthy_donor-cDC|World / disease group, cell group and cell class (v2) | 7.33e-06 | 197 | 105 | 6 | a545fe3a80cd721bf01115bbb645753840ec9f40 | |
| ToppCell | mild_COVID-19-cDC|mild_COVID-19 / disease group, cell group and cell class (v2) | 7.33e-06 | 197 | 105 | 6 | 44ebd3f967779bb7753fc6dcd9fde6d682f9ccd6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC2-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.55e-06 | 198 | 105 | 6 | c58e2d3a21fcca9f1accccc5303ca4222b6c8432 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC2|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.55e-06 | 198 | 105 | 6 | f4ff9520598ebc52b3a1f31eee766957983e16b4 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Myeloid-Dendritic_cells-mDC|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.55e-06 | 198 | 105 | 6 | e8002972410e4803d85263ba2642e6855cef83e9 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Schwann-Schwann_nonmyelinating|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.77e-06 | 199 | 105 | 6 | a92718a3f1153b8d2196fd343ed5bc0ebc98cad7 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.77e-06 | 199 | 105 | 6 | 5f350d9c7da9ac111bf22623dd4fed7f7983c9fc | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Schwann|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.77e-06 | 199 | 105 | 6 | 8dc65662c3ca1db2ba0091332f0658abc0afc5de | |
| ToppCell | Caecum-Dendritic_cell|Caecum / Region, Cell class and subclass | 7.99e-06 | 200 | 105 | 6 | b91d3d7505a022ca360ab5b3f9955753d111f974 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.99e-06 | 200 | 105 | 6 | 363a8cebf2ace820661bcb87c7941f6671f8e5f3 | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-ILC|IIF / Disease, condition lineage and cell class | 7.99e-06 | 200 | 105 | 6 | edb0b252e6ff9824908d1ff7d0d42710b00949c8 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 7.99e-06 | 200 | 105 | 6 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 7.99e-06 | 200 | 105 | 6 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type. | 7.99e-06 | 200 | 105 | 6 | 2a635694844ddabcd98462c5636a6f41a3f08a46 | |
| ToppCell | Caecum-(5)_Dendritic_cell|Caecum / shred on region, Cell_type, and subtype | 7.99e-06 | 200 | 105 | 6 | aa87810706fd4164085d8e973359b68a2691842e | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Tacstd2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.26e-05 | 143 | 105 | 5 | 24fd24846fbef049af669a57d42fcc18928d2b27 | |
| ToppCell | droplet-Fat-Scat-21m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-05 | 151 | 105 | 5 | 79827a76c675dcb82f59c0a45d0f962b02d5bfd6 | |
| ToppCell | severe_COVID-19-cDC|World / disease group, cell group and cell class (v2) | 3.43e-05 | 156 | 105 | 5 | 0a7e18ed8e13261c405eb6b9a183e99d8e1aac37 | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.43e-05 | 156 | 105 | 5 | af47a4b17342bdb3cb62d7e2d52a81168e588629 | |
| ToppCell | severe_COVID-19-cDC|severe_COVID-19 / disease group, cell group and cell class (v2) | 3.54e-05 | 157 | 105 | 5 | ec1978e07e2214048d015d8bb793c1d9991f6e37 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 3.99e-05 | 161 | 105 | 5 | 537a1d86de99a493b0345ca0f760994260e97049 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.11e-05 | 162 | 105 | 5 | 75df7ff779a3b9159ba97d852da1f8df650b9ce5 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.61e-05 | 166 | 105 | 5 | 6a6ed5c7a43fee9a8a9be42dfa99303815b8e8ef | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.75e-05 | 167 | 105 | 5 | 91b14df450bfb6a2b406c88f8c75cd51eeb9e82b | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.75e-05 | 167 | 105 | 5 | 17c653b46507c8bb85da95836ae72a6015336142 | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.02e-05 | 169 | 105 | 5 | 3e40ae0b23a962e0f15908872dec63f51c5b8b83 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-05 | 169 | 105 | 5 | 46f0f0de9a0894c454f93032e7a7a800f47c8276 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.02e-05 | 169 | 105 | 5 | 9c9bb1b32fc6e22359424a262178906c3954415d | |
| ToppCell | Immune-dendritic_cell|World / Lineage, Cell type, age group and donor | 5.31e-05 | 171 | 105 | 5 | 6a9e2e2d3e1d8cc475bf9765129bc4a32da3b8ea | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.46e-05 | 172 | 105 | 5 | a125ac2db9c8ece95970a93aa6f7918d1dcef886 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.46e-05 | 172 | 105 | 5 | 62ed3b70fa1f6c84ea80ff00f60d2562be292e9d | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.46e-05 | 172 | 105 | 5 | 6aab59add5b180cee0ca31179c620e89d352d5c1 | |
| ToppCell | 5'-Adult-Distal_Rectal-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.61e-05 | 173 | 105 | 5 | b335ca2a247156eba821943b2b9fc9922230b409 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-05 | 173 | 105 | 5 | 513b4d31bcfb269556c6b4cc389865fb12e52c4f | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.61e-05 | 173 | 105 | 5 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.77e-05 | 174 | 105 | 5 | 778e0317c0c63fa4efd74114feb760975b819d92 | |
| ToppCell | 10x3'2.3-week_17-19-Neuro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.93e-05 | 175 | 105 | 5 | bbce8b1a160b414c0bf643c21c4e5e78fbccb7e1 | |
| ToppCell | 10x3'2.3-week_17-19-Neuro-stroma-schwann_cells|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.93e-05 | 175 | 105 | 5 | 8b010220cdfb680ec839572f4933adfb85045ea6 | |
| ToppCell | 10x3'2.3-week_17-19-Neuro-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.93e-05 | 175 | 105 | 5 | 0b579aeadcc06be83627391c0b01bd8605fdbdf3 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.09e-05 | 176 | 105 | 5 | ad05dd934f4ac2e656b3455de091f4c8772de6c8 | |
| ToppCell | ILEUM-inflamed-(9)_Enteric_neurons|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.43e-05 | 178 | 105 | 5 | d9142151819afb0dc22bfb32a9c9dba5f553067d | |
| ToppCell | ILEUM-inflamed-(9)_Neuro_cell|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.43e-05 | 178 | 105 | 5 | 611504b0a9e6318b18fba83787b03f9245c82252 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.77e-05 | 180 | 105 | 5 | 38490017dd590e3fcfa7e88d8d15235d55f90cf1 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.77e-05 | 180 | 105 | 5 | 2ccc77d769d3ffd77ab3af45e4f192785b6db79c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.77e-05 | 180 | 105 | 5 | 788d5fbf688365b5d92d3aa19b9f8e9448f8be5a | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.14e-05 | 182 | 105 | 5 | b4fc5e4f5d8440a3c9ee0a6fd0da87b43cabc8c6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.14e-05 | 182 | 105 | 5 | f96095b81188b52db8fcfca4837129cfcd9bd7b7 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-macrophage|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.14e-05 | 182 | 105 | 5 | df26388c0c46d1c4775103c8e802937b4d4e7470 | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.14e-05 | 182 | 105 | 5 | b8be66a867ea1bbae0820b26dbd55b68611f5ad5 | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.14e-05 | 182 | 105 | 5 | cb488f9a9b200e2557335ccf22535cd247512cdc | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 7.32e-05 | 183 | 105 | 5 | 818fd886e0188091310825f9145fa53328f2c979 | |
| Drug | tocainide | 2.24e-07 | 30 | 103 | 5 | CID000038945 | |
| Drug | clenbuterol | 2.71e-07 | 142 | 103 | 8 | CID000002783 | |
| Drug | dmid | 3.82e-07 | 14 | 103 | 4 | CID000151469 | |
| Drug | dopamine-4-O-sulfate | 3.11e-06 | 7 | 103 | 3 | CID000123932 | |
| Drug | 2-naphthylsulfate | 3.11e-06 | 7 | 103 | 3 | CID000074428 | |
| Drug | 2-iodo-4-azidophenol | 3.11e-06 | 7 | 103 | 3 | CID003035977 | |
| Drug | luciferyl sulfate | 3.11e-06 | 7 | 103 | 3 | CID011953812 | |
| Drug | formycin triphosphate | 3.42e-06 | 51 | 103 | 5 | CID000122274 | |
| Drug | AC1NSN3X | 4.56e-06 | 54 | 103 | 5 | CID005366189 | |
| Drug | AC1NT1AF | 4.64e-06 | 25 | 103 | 4 | CID005322157 | |
| Drug | dopamine 3-O-sulfate | 4.95e-06 | 8 | 103 | 3 | CID000122136 | |
| Drug | 6-anilino-2-thiouracil | 4.95e-06 | 8 | 103 | 3 | CID003037707 | |
| Drug | 2-iodophenol | 4.95e-06 | 8 | 103 | 3 | CID000010784 | |
| Drug | Pirmenolum | 5.47e-06 | 26 | 103 | 4 | CID000004853 | |
| Drug | purealin | 6.51e-06 | 58 | 103 | 5 | CID006419303 | |
| Drug | Methylmercury Compounds | ARPP19 NPEPPS ANXA6 GPX4 IPP ARFGEF1 RPS24 NDRG2 STAT3 FABP7 FREM2 EEF2 TIMP1 ELAVL4 VDAC3 | 6.54e-06 | 851 | 103 | 15 | ctd:D008767 |
| Drug | isoproterenol | MYH10 MYO1A MYO1C MYO1D SIK1 MYO1B TIMP1 NISCH SCN3A SCN7A SCN9A IK TAT | 1.02e-05 | 669 | 103 | 13 | CID000003779 |
| Drug | gabapentin | 1.19e-05 | 169 | 103 | 7 | CID000003446 | |
| Drug | mexiletine | 1.23e-05 | 66 | 103 | 5 | CID000004178 | |
| Drug | AC1N9ZT2 | 1.46e-05 | 33 | 103 | 4 | CID004369234 | |
| Drug | B0683 | 1.54e-05 | 117 | 103 | 6 | CID006398969 | |
| Drug | T2755 | 1.77e-05 | 71 | 103 | 5 | CID000005514 | |
| Drug | 16-BAC | 1.92e-05 | 12 | 103 | 3 | CID000031202 | |
| Drug | xanthanoic acid | 2.03e-05 | 2 | 103 | 2 | CID000065736 | |
| Drug | talatisamine | 2.03e-05 | 2 | 103 | 2 | CID000159891 | |
| Drug | JP8 aviation fuel | CAMK2G ANXA6 GPX4 ALDH1L1 PGK1 FABP3 PARP1 EEF2 TIMP1 DNASE1L3 | 2.06e-05 | 419 | 103 | 10 | ctd:C098607 |
| Drug | EM-139 | 2.49e-05 | 13 | 103 | 3 | CID000131427 | |
| Drug | aprindine | 2.59e-05 | 38 | 103 | 4 | CID000002218 | |
| Drug | Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Up 200; 16.4uM; MCF7; HT_HG-U133A | 2.63e-05 | 191 | 103 | 7 | 2824_UP | |
| Drug | (S)-(-)-Cycloserine [339-72-0]; Up 200; 39.2uM; PC3; HT_HG-U133A | 3.00e-05 | 195 | 103 | 7 | 3789_UP | |
| Drug | naphthalenemethanol | 3.16e-05 | 14 | 103 | 3 | CID000020908 | |
| Drug | deoxoestrone | 3.16e-05 | 14 | 103 | 3 | CID000005888 | |
| Drug | S-ropivacaine | 3.18e-05 | 40 | 103 | 4 | CID000071273 | |
| Drug | Ajmalicine hydrochloride [4373-34-6]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 3.21e-05 | 197 | 103 | 7 | 2898_UP | |
| Drug | AC1L9HHR | 3.33e-05 | 354 | 103 | 9 | CID000445141 | |
| Drug | Methylhydantoin-5-(L) [40856-73-3]; Down 200; 35uM; PC3; HT_HG-U133A | 3.53e-05 | 200 | 103 | 7 | 4618_DN | |
| Drug | arylsulfate | 3.93e-05 | 15 | 103 | 3 | CID000074426 | |
| Drug | cyclobenzaprine | 3.93e-05 | 15 | 103 | 3 | CID000002895 | |
| Drug | A-44 | 4.82e-05 | 16 | 103 | 3 | CID000120353 | |
| Drug | benzilic acid | 5.84e-05 | 17 | 103 | 3 | CID000006463 | |
| Drug | aurintricarboxylic acid | 5.87e-05 | 91 | 103 | 5 | CID000002259 | |
| Drug | fenobam | 6.06e-05 | 3 | 103 | 2 | CID000162834 | |
| Drug | N-(2-methyl-3-(4-(4-(4-(trifluoromethoxy)benzyloxy)piperidin-1-yl)-1,3,5-triazin-2-ylamino)phenyl)acetamide | 6.06e-05 | 3 | 103 | 2 | ctd:C561228 | |
| Drug | Scorpion Venoms | 6.98e-05 | 18 | 103 | 3 | ctd:D012604 | |
| Drug | GTP[S] | MYO1A MYO1D ARFGEF1 GRM1 GRM5 NISCH SCN3A SCN7A SCN9A GNAI3 IK | 7.57e-05 | 591 | 103 | 11 | CID000001764 |
| Drug | AC1Q6OHG | 8.27e-05 | 19 | 103 | 3 | CID000115063 | |
| Drug | pedunculagin | 8.27e-05 | 19 | 103 | 3 | CID000442688 | |
| Drug | diprafenone | 8.27e-05 | 19 | 103 | 3 | CID000071249 | |
| Drug | propafenone | 8.36e-05 | 98 | 103 | 5 | CID000004932 | |
| Drug | S-(-)-Etomoxir | 9.20e-05 | 100 | 103 | 5 | CID000060765 | |
| Drug | PLP-Glu | 9.69e-05 | 20 | 103 | 3 | CID000444293 | |
| Drug | N-hydroxy-2-aminofluorene | 1.13e-04 | 21 | 103 | 3 | CID000005895 | |
| Drug | ethyl isothiocyanate | 1.21e-04 | 4 | 103 | 2 | CID000010966 | |
| Drug | Cbpg | 1.21e-04 | 4 | 103 | 2 | CID005311040 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 1.25e-04 | 170 | 103 | 6 | 6736_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 1.29e-04 | 171 | 103 | 6 | 4237_UP | |
| Drug | MeA alpha C | 1.30e-04 | 22 | 103 | 3 | CID000062244 | |
| Drug | AABSSN | 1.30e-04 | 22 | 103 | 3 | CID005464134 | |
| Drug | AC1LC61J | 1.48e-04 | 59 | 103 | 4 | CID000548548 | |
| Drug | taselin | 1.49e-04 | 23 | 103 | 3 | CID000023846 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 1.51e-04 | 176 | 103 | 6 | 4565_UP | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A | 1.51e-04 | 176 | 103 | 6 | 6546_UP | |
| Drug | bromfenacoum | MYH10 ACLY NPEPPS ALDH1L1 DPP8 RUFY3 FABP3 FABP7 EEF2 BAIAP2 IK | 1.61e-04 | 644 | 103 | 11 | ctd:C013418 |
| Drug | epoxiconazole | 1.61e-04 | 341 | 103 | 8 | ctd:C109476 | |
| Drug | AalphaC | 1.70e-04 | 24 | 103 | 3 | CID000062805 | |
| Drug | INH2BP | 1.70e-04 | 24 | 103 | 3 | CID000072356 | |
| Drug | 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide | 1.70e-04 | 24 | 103 | 3 | ctd:C518860 | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A | 1.81e-04 | 182 | 103 | 6 | 7503_UP | |
| Drug | blebbistatin | 1.85e-04 | 116 | 103 | 5 | CID003476986 | |
| Drug | ketamine | 1.91e-04 | 262 | 103 | 7 | CID000003821 | |
| Drug | AzMC | 1.92e-04 | 25 | 103 | 3 | CID000064986 | |
| Drug | minoxidil sulphate | 1.92e-04 | 25 | 103 | 3 | CID000004202 | |
| Drug | 2-pentanone | 1.92e-04 | 25 | 103 | 3 | CID000007895 | |
| Drug | corticosterone hemisuccinate | 2.01e-04 | 5 | 103 | 2 | CID000159273 | |
| Drug | DMeOB | 2.01e-04 | 5 | 103 | 2 | CID002061047 | |
| Drug | AC1LCUX7 | 2.01e-04 | 5 | 103 | 2 | CID000656420 | |
| Drug | Dp-ba | 2.01e-04 | 5 | 103 | 2 | CID006440149 | |
| Drug | Acamprosate | 2.01e-04 | 5 | 103 | 2 | DB00659 | |
| Drug | LY393675 | 2.01e-04 | 5 | 103 | 2 | CID005311262 | |
| Drug | tyrphostin B52 | 2.01e-04 | 5 | 103 | 2 | CID005328773 | |
| Drug | triethylammonium chloride | 2.01e-04 | 5 | 103 | 2 | CID000011130 | |
| Drug | AC1L1CQC | 2.16e-04 | 65 | 103 | 4 | CID000002012 | |
| Drug | JP-8 | 2.17e-04 | 26 | 103 | 3 | CID000054931 | |
| Drug | alpha-methyldopamine | 2.17e-04 | 26 | 103 | 3 | CID000017005 | |
| Drug | glycolithocholic acid | 2.17e-04 | 26 | 103 | 3 | CID000115245 | |
| Drug | 1m2q | 2.17e-04 | 26 | 103 | 3 | CID005326637 | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A | 2.22e-04 | 189 | 103 | 6 | 5587_UP | |
| Drug | disopyramide | 2.30e-04 | 66 | 103 | 4 | CID000003114 | |
| Drug | Fenoterol hydrobromide [1944-12-3]; Down 200; 10.4uM; HL60; HT_HG-U133A | 2.41e-04 | 192 | 103 | 6 | 2378_DN | |
| Drug | Nitrendipine [39562-70-4]; Up 200; 11uM; HL60; HT_HG-U133A | 2.41e-04 | 192 | 103 | 6 | 3087_UP | |
| Drug | mAHP | 2.43e-04 | 27 | 103 | 3 | CID000220531 | |
| Drug | PbTx-1 | 2.43e-04 | 27 | 103 | 3 | CID006437089 | |
| Drug | AC1L1MOZ | 2.43e-04 | 27 | 103 | 3 | CID000031958 | |
| Drug | nefopam | 2.43e-04 | 27 | 103 | 3 | CID000004450 | |
| Drug | Piribedil hydrochloride [78213-63-5]; Down 200; 12uM; MCF7; HT_HG-U133A | 2.62e-04 | 195 | 103 | 6 | 3512_DN | |
| Drug | Triflusal [322-79-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 2.62e-04 | 195 | 103 | 6 | 7451_DN | |
| Drug | CP-690334-01 [459212-38-5]; Up 200; 10uM; PC3; HT_HG-U133A | 2.62e-04 | 195 | 103 | 6 | 4558_UP | |
| Drug | Tocainide hydrochloride; Down 200; 17.4uM; PC3; HT_HG-U133A | 2.70e-04 | 196 | 103 | 6 | 4256_DN | |
| Drug | (-)-Eseroline fumarate salt [104015-29-4]; Down 200; 12uM; MCF7; HT_HG-U133A | 2.70e-04 | 196 | 103 | 6 | 7027_DN | |
| Drug | Cefmetazole sodium salt [56796-39-5]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 2.70e-04 | 196 | 103 | 6 | 7222_DN | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 4.59e-06 | 10 | 101 | 3 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 4.59e-06 | 10 | 101 | 3 | DOID:0080422 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | DNAH3 ATP7B GPX4 IPP ARFGEF1 MYO1B ALDH1L1 PTPRU GRM1 PARP1 FAT1 DNASE1L3 | 5.17e-06 | 702 | 101 | 12 | C0009402 |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 8.37e-06 | 12 | 101 | 3 | DOID:0060170 (implicated_via_orthology) | |
| Disease | myo-inositol measurement | 1.16e-05 | 2 | 101 | 2 | EFO_0800621 | |
| Disease | Cryptophthalmos syndrome | 3.47e-05 | 3 | 101 | 2 | C0265233 | |
| Disease | FRASER SYNDROME 1 | 3.47e-05 | 3 | 101 | 2 | C4551480 | |
| Disease | Fraser syndrome (implicated_via_orthology) | 6.93e-05 | 4 | 101 | 2 | DOID:0090001 (implicated_via_orthology) | |
| Disease | lupus nephritis | 1.97e-04 | 33 | 101 | 3 | EFO_0005761 | |
| Disease | carotid plaque build | 2.02e-04 | 84 | 101 | 4 | EFO_0006501 | |
| Disease | unipolar depression, bipolar disorder | 2.04e-04 | 156 | 101 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | serine:glycine ratio | 2.41e-04 | 7 | 101 | 2 | EFO_0021777 | |
| Disease | X-linked infantile spasms | 3.20e-04 | 8 | 101 | 2 | C4552072 | |
| Disease | Unilateral agenesis of kidney | 3.20e-04 | 8 | 101 | 2 | C0266294 | |
| Disease | Aqueductal Stenosis | 3.20e-04 | 8 | 101 | 2 | C2936786 | |
| Disease | Congenital small ears | 3.78e-04 | 41 | 101 | 3 | C0152423 | |
| Disease | epilepsy | 3.78e-04 | 41 | 101 | 3 | EFO_0000474 | |
| Disease | hair colour measurement, eye colour measurement, skin pigmentation measurement | 5.13e-04 | 10 | 101 | 2 | EFO_0007009, EFO_0007822, EFO_0009764 | |
| Disease | Tourette syndrome | 6.79e-04 | 50 | 101 | 3 | EFO_0004895 | |
| Disease | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | 9.43e-04 | 328 | 101 | 6 | EFO_0008377, EFO_0008378 | |
| Disease | Inflammation | 9.68e-04 | 127 | 101 | 4 | C0021368 | |
| Disease | energy intake | 1.18e-03 | 134 | 101 | 4 | EFO_0003939 | |
| Disease | Hepatitis | 1.18e-03 | 15 | 101 | 2 | C0019158 | |
| Disease | Neuralgia, Supraorbital | 1.35e-03 | 16 | 101 | 2 | C0038870 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 1.35e-03 | 16 | 101 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | Neuralgia | 1.35e-03 | 16 | 101 | 2 | C0027796 | |
| Disease | vision disorder | 1.35e-03 | 16 | 101 | 2 | MONDO_0021084 | |
| Disease | Neuralgia, Atypical | 1.35e-03 | 16 | 101 | 2 | C0234247 | |
| Disease | Neuralgia, Stump | 1.35e-03 | 16 | 101 | 2 | C0234249 | |
| Disease | Neuralgia, Iliohypogastric Nerve | 1.35e-03 | 16 | 101 | 2 | C0423712 | |
| Disease | Neuralgia, Perineal | 1.35e-03 | 16 | 101 | 2 | C0423711 | |
| Disease | autism spectrum disorder (is_implicated_in) | 1.35e-03 | 16 | 101 | 2 | DOID:0060041 (is_implicated_in) | |
| Disease | Paroxysmal Nerve Pain | 1.35e-03 | 16 | 101 | 2 | C0751373 | |
| Disease | Nerve Pain | 1.35e-03 | 16 | 101 | 2 | C0751372 | |
| Disease | Neuralgia, Ilioinguinal | 1.35e-03 | 16 | 101 | 2 | C0751371 | |
| Disease | Neuralgia, Vidian | 1.35e-03 | 16 | 101 | 2 | C0042656 | |
| Disease | heart disease (biomarker_via_orthology) | 1.53e-03 | 17 | 101 | 2 | DOID:114 (biomarker_via_orthology) | |
| Disease | sleep duration | 1.56e-03 | 362 | 101 | 6 | EFO_0005271 | |
| Disease | Mammary Carcinoma, Human | 2.21e-03 | 525 | 101 | 7 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 2.21e-03 | 525 | 101 | 7 | C1257931 | |
| Disease | Mammary Neoplasms | 2.26e-03 | 527 | 101 | 7 | C1458155 | |
| Disease | pulmonary function measurement | 2.37e-03 | 77 | 101 | 3 | EFO_0003892 | |
| Disease | Breast Carcinoma | 2.54e-03 | 538 | 101 | 7 | C0678222 | |
| Disease | Attention Deficit Disorder | 2.56e-03 | 22 | 101 | 2 | C0041671 | |
| Disease | Minimal Brain Dysfunction | 2.56e-03 | 22 | 101 | 2 | C1321905 | |
| Disease | anxiety disorder (implicated_via_orthology) | 2.56e-03 | 22 | 101 | 2 | DOID:2030 (implicated_via_orthology) | |
| Disease | Down syndrome (is_marker_for) | 2.56e-03 | 22 | 101 | 2 | DOID:14250 (is_marker_for) | |
| Disease | Colorectal Neoplasms | 2.68e-03 | 277 | 101 | 5 | C0009404 | |
| Disease | Epilepsy, Benign Psychomotor, Childhood | 2.80e-03 | 23 | 101 | 2 | C0393672 | |
| Disease | Epilepsy, Lateral Temporal | 2.80e-03 | 23 | 101 | 2 | C0393682 | |
| Disease | idiopathic pulmonary fibrosis (is_marker_for) | 2.80e-03 | 23 | 101 | 2 | DOID:0050156 (is_marker_for) | |
| Disease | Uncinate Epilepsy | 2.80e-03 | 23 | 101 | 2 | C0014558 | |
| Disease | Epilepsy, Temporal Lobe | 2.80e-03 | 23 | 101 | 2 | C0014556 | |
| Disease | Alveolitis, Fibrosing | 2.93e-03 | 83 | 101 | 3 | C4721507 | |
| Disease | Attention deficit hyperactivity disorder | 3.05e-03 | 24 | 101 | 2 | C1263846 | |
| Disease | Hepatolenticular Degeneration | 3.05e-03 | 24 | 101 | 2 | C0019202 | |
| Disease | West Syndrome | 3.05e-03 | 24 | 101 | 2 | C0037769 | |
| Disease | Hepatic Form of Wilson Disease | 3.05e-03 | 24 | 101 | 2 | C1527352 | |
| Disease | Pulmonary Fibrosis | 3.14e-03 | 85 | 101 | 3 | C0034069 | |
| Disease | colon adenocarcinoma (is_marker_for) | 3.31e-03 | 25 | 101 | 2 | DOID:234 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DVFNKGYGFGMVKID | 16 | Q9Y277 | |
| AFKEKYMEFDLNNEG | 51 | Q9BQI0 | |
| GQKYFDSGDYNMAKA | 61 | O43768 | |
| PEGGSEMFVYKQAFK | 1306 | Q8TER5 | |
| PAMKKSFAFDNVGYE | 31 | P35670 | |
| FLGDNDKFNKEVMYA | 751 | Q9Y6D6 | |
| KGFLKYMDNQSFATE | 181 | Q86TY3 | |
| KCKGFGFVTMTNYDE | 341 | P26378 | |
| AGAKYFFKSMDQDFG | 51 | O14641 | |
| GQKYFDSGDYNMAKA | 56 | P56211 | |
| AEALYTAMKGFGSDK | 26 | P08133 | |
| GGAYAFLKFQNLDMA | 376 | Q8NDT2 | |
| YFAALFTGGMKESSK | 61 | Q9Y573 | |
| FGKGIYFADMVSKSA | 891 | P09874 | |
| ESMFSLADKDGNGYL | 821 | Q9NRD9 | |
| AFKDFILSKGYEMPG | 981 | Q5HY64 | |
| GNIGEKFSMDYKTGA | 1921 | Q14517 | |
| FKTMDFGKFDQIYDV | 1231 | Q8IY17 | |
| SLAEMDYKGAFSKGQ | 3681 | Q86XX4 | |
| FKEMGKDYFDYINVG | 471 | P41594 | |
| MFEYAKDFLGSGDPK | 731 | Q9HBG6 | |
| FTVDMEKGAKGFGFS | 1146 | Q86UL8 | |
| AMKDALDSGKYNGYA | 96 | P17735 | |
| FKDLYFKMFDVGGQR | 191 | P08754 | |
| KYMDIEFDFKGSPLG | 161 | Q9UBC5 | |
| MFYFAVEDGGGNKLT | 1746 | Q5SZK8 | |
| NFDDYMKSLGVGFAT | 16 | P05413 | |
| MQKGFNDKFCYGDIT | 776 | Q8NEN9 | |
| DGLDYLAMGKFFKGL | 1281 | Q6ZR08 | |
| GKFQVDTGAKFYRGM | 81 | Q9UII6 | |
| TFGEMADAFKSDYFN | 381 | Q9UGL1 | |
| GGFLMKKELNYFAKA | 186 | P00558 | |
| IDFVGELNDKMKGFY | 146 | A6NEC2 | |
| VKNVMDKNGDAYGFY | 56 | Q6P4A8 | |
| MKTAEGYGFKQEYES | 886 | Q92729 | |
| FAYQVAKGMEFLEFK | 791 | P36888 | |
| FMGDFNAGCSYVPKK | 186 | Q13609 | |
| DPAVMGGFAKYEKAF | 1536 | Q92608 | |
| SDGLDYKAMGKFFKG | 1456 | Q8TD57 | |
| YKAMGKFFKGLAQAG | 1461 | Q8TD57 | |
| KIGFEKEGMSYLDFA | 681 | Q5THR3 | |
| KEGMSYLDFAAGFED | 686 | Q5THR3 | |
| DDYKKMGTLFGELNK | 66 | Q8N8J7 | |
| GLKFEGAFKYKMGQI | 711 | Q6V1X1 | |
| LDMKIGQGKYEQGFF | 641 | Q6ZUT9 | |
| KYYVAMDFQAKLGDG | 161 | Q6P179 | |
| LLFGYDSFGNMCGKK | 61 | Q8N4M1 | |
| KTGEKYFFGGFLNQM | 491 | Q9UHC6 | |
| MYVAKFAAKGEGQLG | 231 | P13639 | |
| NFDEYMKALGVGFAT | 16 | O15540 | |
| IKEFAAGYNVKFDMF | 116 | P36969 | |
| YGESGMDAFKELAAQ | 236 | Q13255 | |
| EMVYSLFKAKLGDQG | 151 | Q5T7M9 | |
| IDFVGELNDKMKGFY | 146 | P55786 | |
| GMDFHKFYFENLLSK | 471 | Q13555 | |
| ETAFGSAYKTKKGMF | 636 | P35580 | |
| SPFEAMFGYKAKFGL | 406 | Q6ZNG9 | |
| MGYDSLKNGEEFSFL | 76 | Q99574 | |
| IDFSMYLKDGNSSKG | 236 | Q7L099 | |
| EFYEKFMSGKVVGGS | 166 | Q6IMI6 | |
| SGFDEKMFLKRGGKY | 336 | Q8WXG1 | |
| GKLTEAFKYFLQGMG | 301 | Q9UN36 | |
| TMSVEDFFYGLFKNG | 236 | Q8N4C6 | |
| YSKLGCFEIAKMEGF | 891 | O60502 | |
| FMAKEGEYGKFFVTL | 201 | Q68EM7 | |
| EEAFKAGMFGKETYV | 1626 | P58107 | |
| FGMSNFAYVKKEDGI | 1661 | Q15858 | |
| FAYVKKEDGINDMFN | 1666 | Q15858 | |
| KDMKTKYFFFDDGNG | 121 | P61009 | |
| MDIKLADFGFGNFYK | 161 | A0A0B4J2F2 | |
| MDIKLADFGFGNFYK | 161 | P57059 | |
| YSFAAVGGMEGLKEK | 221 | Q8WWX8 | |
| LAFYNDGKDKEMVSF | 551 | Q9NT68 | |
| FAVVGMQLFGKSYKE | 896 | Q9NY46 | |
| IFGMSNFAYVKKEAG | 1671 | Q9NY46 | |
| NFAYVKKEAGIDDMF | 1676 | Q9NY46 | |
| EFLMKNSDLYGAKGA | 476 | Q8NEM2 | |
| YKVLFKMFLGSANFG | 346 | A4IF30 | |
| MAQGVIEYKEKFGFD | 126 | Q15120 | |
| DSFLEKFMAGEVSYG | 156 | P0DMN0 | |
| DSFLEKFMAGEVSYG | 156 | P0DMM9 | |
| GGALDAAAKMFSKAF | 936 | P53396 | |
| TYAAKGYFDALVKMG | 46 | Q9UQB8 | |
| DGKMILASNFFKGAA | 296 | O75891 | |
| KENMKFETGAFSYYG | 626 | Q6P4Q7 | |
| TKMYKGFQALGDAAD | 66 | P01033 | |
| MFVTGFGALKNDGYS | 311 | Q9UL52 | |
| FMGGSFYALQKKEQG | 411 | O15375 | |
| ESFLEKFMAGEVSYG | 156 | P50226 | |
| DFDFNYKTLKSQGDM | 171 | P40763 | |
| TLFDMGKNKYCFDFG | 306 | Q9NS62 | |
| GMFGAGIYFAENSSK | 1206 | O95271 | |
| GFGMIYDSLDYAKKN | 71 | P62847 | |
| DFYSEFGNKTTGKME | 1291 | Q9Y2I1 | |
| KFDPMGKYFATGSAD | 231 | Q96J01 | |
| GKKFENTEMFGQYPL | 311 | Q9UHP3 | |
| MVQLFEKGYGKDAAG | 486 | P08240 | |
| KANDKGRNKGFEAMY | 71 | A0A075B6T8 | |
| DKKQLGDFFGMSNSY | 431 | Q13123 | |
| FVSEDNMAFGKPAKY | 91 | Q9H0R3 | |
| SAAFGMKLFGKNYEE | 641 | Q01118 | |
| VFGMYNFAYVKKEAG | 1396 | Q01118 | |
| GKNATYFSMADKVEG | 1121 | Q6R2W3 | |
| LMEGSYNKVFLAKGN | 236 | P48556 | |
| NSALEYFGEMLKAAG | 956 | Q9H9Y6 | |
| DMATGKSKGYGFVSF | 131 | Q01085 | |
| TEFKGEIMFYKKNGS | 91 | Q96L42 | |
| FGKYMDIEFDFKGDP | 166 | O43795 | |
| SRFGKYMDVQFDFKG | 196 | O00159 | |
| RFGKYMDINFDFKGD | 161 | O94832 | |
| RFGKYMDINFDFKGD | 161 | B0I1T2 | |
| GFYKCMAKNILGSDS | 2806 | Q9NR99 | |
| GDPEELMFQYFKKFG | 346 | Q14CX7 | |
| NFDDYMKALGVGLAT | 16 | P02689 | |
| DYEKAKGKMVGFQSL | 1091 | P20929 |